vancomycin has been researched along with cefotaxime in 165 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 16 (9.70) | 18.7374 |
1990's | 45 (27.27) | 18.2507 |
2000's | 61 (36.97) | 29.6817 |
2010's | 31 (18.79) | 24.3611 |
2020's | 12 (7.27) | 2.80 |
Authors | Studies |
---|---|
Apiwattanakul, N; Endou, H; Jariyawat, S; Kanai, Y; Sekine, T; Sophasan, S; Takeda, M | 1 |
Boyle, TP; Marotti, KR; Sweeney, MT; Thorarensen, A; Zurenko, GE | 1 |
Aghatabay, NM; Dülger, B; Haciu, D; Karabiyik, T; Neshat, A; Somer, M | 1 |
Fiett, J; Gniadkowski, M; Grzesiowski, P; Hryniewicz, W; Izdebski, R; Sadowy, E | 1 |
Aghatabay, NM; Dulger, B; Gucin, F; Senel, M; Somer, M | 1 |
Cottagnoud, M; Cottagnoud, P; Schaffner, T; Stucki, A; Winkelmann, V | 1 |
Kwon, DH; Lu, CD | 1 |
Chang, CL; Jeong, J; Jeong, SH; Jung, HJ; Kim, HR; Kim, S; Lee, EY; Lee, JN; Shin, JH | 1 |
Ardanuy, C; Bouza, E; Calatayud, L; Cercenado, E; Fenoll, A; Liñares, J; Martín, R; Pallares, R | 1 |
Chen, T; Khalil, H; Riffon, R; Wang, R; Wang, Z | 1 |
Chang, KY; Ho, YH; Hsieh, YC; Hsueh, PR; Huang, LM; Huang, YC; Lin, HC | 1 |
Aghatabay, NM; Cevik, H; Dulger, B; Mahmiani, Y | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Ahsman, MJ; Mathot, RA; Tibboel, D; Wildschut, ED | 1 |
Banères-Roquet, F; Gualtieri, M; Leonetti, JP; Pugnière, M; Villain-Guillot, P | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Cao, Z; Dai, C; Li, S; Li, W; Ma, Y; Wu, Y; Zhao, R; Zhao, Z | 1 |
Aghatabay, NM; Baş, A; Dülger, B; Gücin, F; Kircali, A; Sen, G; Yazicioğlu, MB | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Cai, L; Gilbert, GL; Kong, F; Oftadeh, S; Xiao, M; Xu, X; Zhou, F | 1 |
Ardanuy, C; Brito-Avô, A; Gonçalo-Marques, J; Liñares, J; Morais, A; Pires, R; Rolo, D; Santos-Sanches, I | 1 |
Bavari, S; Bowlin, TL; Butler, MM; Moir, DT; Panchal, RG; Peet, NP; Shinabarger, DL; Williams, JD | 1 |
Franzyk, H; Frimodt-Møller, N; Jahnsen, RD; Nielsen, HM; Sandberg-Schaal, A; Vissing, KJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Benfodda, Z; Bénimèlis, D; Boibessot, T; Dunyach-Rémy, C; Lavigne, JP; Lebeau, A; Meffre, P; Szurmant, H; Zschiedrich, CP | 1 |
Arya, G; Dalal, P; Kaur, M; Nimesh, S; Salunke, DB; Singh, R; Singla, P | 1 |
Ali, Z; Bae, JY; Chittiboyina, AG; Khan, IA; Viljoen, AM; Wang, YH; Zaki, AA | 1 |
Klein, CD; van Oosten, LN | 1 |
Ba, Z; Chang, L; Gou, S; Li, B; Liu, H; Ni, J; Ouyang, X; Zhang, J; Zhang, T; Zhang, Y; Zhong, C; Zhu, N; Zhu, Y | 1 |
Guo, Y; Jia, G; Li, L; Wang, J; Wei, L; Xu, X; Yang, Y; Yu, Q; Zhou, Y | 1 |
Klaus, G; Mehls, O; Querfeld, U; Schäfer, F; Soergel, M; Wolf, S | 1 |
Barakett, V; Burghoffer, B; Delisle, F; Guidet, B; Lesage, D; Offenstadt, G; Petit, JC; Richard, G; Vergez, P | 1 |
Bincziewski, B; Etter, L; Minkler, P; Shlaes, DM; Vincent, S | 1 |
Brodersen, R; Robertson, A | 1 |
Francom, S; Jaimovich, DG; Kumar, A | 1 |
Dehne, M; el Abed, K; Hofmann, W; Kroh, U; Lennartz, H | 1 |
DiVincenzo, CA; O'Keefe, JP; Tatarowicz, W; Venezio, FR | 1 |
Liu, S; Meyer, RD | 1 |
Arimasu, O; Hiruma, F; Meguro, H; Shiraishi, H; Sugamata, K | 1 |
Brunet, F; Dhainaut, JF; Dreyfus, F; Huyghebaert, MF; Lanore, JJ; Monsallier, JF; Varet, B | 1 |
Finch, R; Martin, J; Pilkington, R | 1 |
Fussell, S; Ginter, GL; Olsen, E; Pendray, M; Scheifele, DW | 1 |
Bogokowsky, B; Chagnac, A; Lurie, B | 1 |
McCracken, GH; Sakata, Y | 1 |
Funada, H; Hattori, K; Ishizaki, T; Kuroda, T; Nakamura, S | 1 |
Bayer, AS; Lam, K | 1 |
Chuah, SK; Dhawan, VK; Maier, MK; Nayyar, M; Thadepalli, H | 1 |
Gugler, R; Steudel, HC | 1 |
Milatović, D | 1 |
Jung, WK | 1 |
Calderwood, SB; Jackson, E; Tung, CC | 1 |
Agbo, P; Carnot, JF; Cayroche, P; Chalvon-Demersay, A; Hacquard, B; Mariani, P | 1 |
Badoual, J; Bergeret, M; Bingen, E; Brahimi, N; Doit, C; Gendrel, D; Raymond, J | 1 |
Bingen, E; Bourrillon, A; Cohen, R | 1 |
Durkin, MR; Lonks, JR; Medeiros, AA; Meyerhoff, AN | 1 |
Sanford, JB | 1 |
Dean, PC; Farquhar, DS; Gremse, DA | 1 |
García Castaño, J; González Parra, S; Muiño Míguez, A; Pinilla Llorente, B | 1 |
Bernaldo de Quirós, JC; Catalán, MJ; Fernández, JM; Suárez, A; Varela de Seijas, E; Vazquez, A | 1 |
John, CC | 1 |
Szof, C; Walker, PC | 1 |
Bein, G; Flocken, W; Gorenflo, M; Vogel, M; Waldschmidt, J | 1 |
Chesney, PJ; Davis, Y; English, BK; Wang, WC | 1 |
Friedland, IR | 1 |
Domingue, G; Efstratiou, A; George, RC; Johnson, AP; Speller, DC; Warner, M | 1 |
Hatori, T; Matsumoto, T; Miyazaki, H; Takashima, K; Tateda, K; Yamaguchi, K | 1 |
García-Rodríguez, JA; Muñoz-Bellido, JL; Muñoz-Criado, S | 1 |
Barreiro Casal, G; Cilleruelo Ortega, MJ; García López, M; Martín Fontelos, P; Mellado Peña, MJ; Pérez Jurado, ML; Villota Arrieta, J | 1 |
Choi, YJ; Hong, T; Kish, A; Millett, W; Ndamukong, J; Win, KK | 1 |
Appelbaum, PC; Jacobs, MR; Visalli, MA | 1 |
Pfeiffer, M; Scholl, E; Wachol-Drewek, Z | 1 |
Appelbaum, PC; Bajaksouzian, S; Jacobs, MR; Visalli, MA | 1 |
Chesney, PJ; English, BK | 1 |
Buisson, M; Champliaud, D; Chavanet, P; Duong, M; Kazmierczak, A; Neuwirth, C; Pechinot, A; Portier, H | 1 |
Allende, H; Almirante, B; Capdevila, JA; Crespo, E; Gavaldà, J; Laguarda, M; Otero, J; Pahissa, A; Pigrau, C; Ruiz, I | 1 |
Ohsawa, R; Okazaki, N; Sata, S; Suzuki, R; Wada, A; Watanabe, H; Watanabe, Y; Yamai, S | 1 |
Exner, H; Finke, U; Joosten, U; Schardey, HM; Schauer, R; Schildberg, FW; Staubach, KH | 1 |
Akram, S; Campos, JM; Donkersloot, JA; Keith, JM; Pikis, A; Rodriguez, WJ | 1 |
Barre, J; Bingen, EH; Bonacorsi, S; Bourrillon, A; Cohen, R; Doit, C | 1 |
de Pablos, M; Lezaun, MJ; López-Bayón, J; Michaus, ML; Pérez-Díaz, L | 1 |
Ashkenazi, S; Rachmel, A; Samra, Z; Steinberg, T | 1 |
Białek, M; Gospodarek, E; Janicka, G; Kania, I; Krawiecka, D; Kruszyńska, E; Mikucka, A; Rózycka, B; Wojak, I | 1 |
Choi, EH; Lee, HJ | 1 |
Aleksic, S; Bockemühl, J; Lehmacher, A; Meier, H | 1 |
Benatar, A; Clybouw, C; Corne, L; Hachimi-Idrissi, S; Ramet, J | 1 |
Jung, S; Kang, SS; Kim, HW; Kim, JH; Kim, SH; Kim, TS; Lee, JH; Lee, JK | 1 |
Bourrillon, A | 1 |
Castañeda, E; de Lencastre, H; Sá-Leão, R; Santos Sanches, I; Tamayo, M | 1 |
Dowell, SF; Leversedge, K; Smith, T; Snitzer, J | 1 |
Dickinson, BP; Lonks, JR; Runarsdottir, V | 1 |
Breiman, RF; Cetron, M; Farley, MM; Fiore, AE; Harrison, LH; Jorgensen, JH; Kolczak, MS; Moroney, JF; Patterson, JE; Schuchat, A | 1 |
Azimi, PH; Brenner, RA; Clark, P; Clemens, J; Gill, V; Lin, FY; Philips, JB; Pratt, E; Regan, J; Rhoads, GG; Troendle, J; Weisman, LE | 1 |
DeFranco, PE; Goebel, J; Lee, B; Shook, LA | 1 |
Kottilil, S; Menon, M; Papudesu, B; Yunis, N | 1 |
Bergh, K; Kolmannskog, S; Skogen, PG | 1 |
Cohen, C; Matthews, RP; Shah, SS | 1 |
Chang, JD; Cho, SH; Ha, YC; Kim, SY; Kim, YH; Koo, KH; Park, HB; Song, HR; Yang, JW | 1 |
Colaert, J; Devlieger, H; Van Caster, A; Vandecasteele, SJ; Verhaegen, J | 1 |
Arisi, A; Beghi, C; Cabassi, A; Campodonico, R; Fiaccadori, E; Gherli, T; Maggiore, U | 1 |
Jog, SM; Patole, SK | 1 |
Kaplan, SL | 1 |
Fandiño, J | 1 |
Bismuth, R; Coriat, P; De Bels, D; Korinek, AM; Puybasset, L; Trystram, D | 1 |
Hesse, Y; Lang, GK; Spraul, CW | 1 |
Barbé, G; Bercion, R; Boucaud-Maitre, Y; Boyer, M; Carricajo, A; Célard, M; Chomarat, M; Clergeau, P; Croizé, J; Delubac, F; Fèvre, D; Fredenucci, I; Fuhrmann, C; Gilles, Y; Gravagna, B; Helfre, M; Lelièvre, H; Letouzey, MN; Mandjee, A; Marchal, MF; Marthelet, P; Meley, R; Perrier-Gros-Claude, JD; Reverdy, ME; Ros, A; Roure, C; Sabot, O; Smati, S; Thierry, J; Tixier, A; Tous, J; Verger, P; Zaoui, E | 1 |
Avila-Agüero, ML; Barton, T; Herrera, JF; Herrera, ML; Ulloa-Gutiérrez, R; Vargas, A | 1 |
Jung, SI; Kiem, S; Kim, SW; Kim, YS; Lee, NY; Oh, WS; Peck, KR; Song, JH; Yun, HJ | 1 |
Avila-Agüero, ML; Huertas, E; Ulloa-Gutierrez, R | 1 |
Sakata, H | 1 |
Dower, SK; Moore, LJ; Pridmore, AC; Read, RC | 1 |
Cambra, F; Fortuny, C; Noguera, A; Palomeque, A; Pons, M | 1 |
Agrappi, C; Clerici, P; Melloni, P; Vasconi, E; Viganò, EF | 1 |
Fougnot, S; Lozniewski, A; Mory, F; Rabaud, C; Schuhmacher, H | 1 |
Bartsch, MS; Schäfer, FK; von Bernstorff, W; Warnke, PH; Wiltfang, J | 1 |
Buckingham, SC; English, BK; Knapp, KM; Luján-Zilbermann, J; McCullers, JA; Orman, KL | 1 |
Caniça, M; Dias, R; Louro, D | 1 |
Hua, CZ; Li, JP; Li, S; Shang, SQ; Ye, H; Yu, HM | 1 |
Charrel, RN; Chaumoitre, K; de Lamballerie, X; Emonet, S; Garnier, JM; Girard, N; Minodier, P; Noel, G; Retornaz, K | 1 |
Barnaud, G; Bouadma, L; Chevrel, G; Dreyfuss, D; Hidri, N; Lacherade, JC; Mourvillier, B; Ricard, JD; Wolff, M | 1 |
Carre, AC; Delabranche, X; Guiot, P; Lefebvre, N; Mootien, Y | 1 |
Chiu, CH; Hsia, SH; Lin, JJ; Wu, CT | 1 |
Janner, DL; McClure, CD; Probert, WS | 1 |
Cengiz, CK | 1 |
Adamcova, J; Bartkovjak, M; Benca, J; Deadline, J; Diana, E; Dudasova, T; Johnson, MJ; Juma, O; Kolenova, A; Muli, JM; Namulanda, V; Njambi, Z; Okoth, V; Pauerova, K; Polonova, J; Rabarova, L; Seckova, S; Sladeckova, V; Steno, J; Takacova, M; Taziarova, M | 1 |
Audard, V; Botterel, F; Bretagne, S; Dahan, K; Dunogue, B; Grimbert, P; Lang, P; Matignon, M | 1 |
Chaimanee, P; Kosalaraksa, P; Lumbiganon, P; Surakunprapha, P | 1 |
Cekinmez, M; Erdogan, B; Sener, L; Tufan, K | 1 |
Ichikawa, Y; Inoue, M; Miyata, H; Shinoda, K; Sugisaka, E; Torii, H | 1 |
Cantagrel, S; Chantreuil, J; Lanotte, P; Mérieau, E | 1 |
Jackson, MA; Mann, K | 1 |
Apiwattanakul, N; Chongtrakool, P; Sirinavin, S; Wanitkun, S | 1 |
Castagnini, LA; DiCaprio, HS; Julapalli, MR; Peña, JA; Phelps, BR; Pirics, ML; Tolle, MA | 1 |
Mittal, MK; Zimmerman, RA | 1 |
Bessou, P; Bing, F; Boubagra, K; Reyt, E; Righini, CA | 1 |
Bhimani, M; Evans, T; Smallfield, A | 1 |
Chakraborty, A; Gloriani, NG; Miyahara, S; Villanueva, SY; Yoshida, S | 1 |
Fung, SY; Lee, ML; Sekaran, SD; Tan, NH | 1 |
Barthelemy, I; Bouchet, A; Mondie, JM; Pham Dang, N | 1 |
Arora, V; Baijal, SS; Lal, R; Poddar, U; Srivastava, A; Yachha, SK | 1 |
Chen, CM; Cheng, YJ; Chuang, YC; Hsu, GJ; Hsueh, PR; Jang, TN; Kung, HC; Li, CF; Liao, CH; Lin, HC; Liu, MF; Liu, YC; Shi, ZY; Tsao, SM; Wang, LS | 1 |
Escassi-Gil, Á; Garrido-Pérez, JI; Lasso-Betancor, CE | 1 |
García López, M; Lisboa, L; Neves, J; Ribeiro, A; Rocha, R; Santos, E | 1 |
Amundsen, E; Asif, M; Eudes, F; Randhawa, H; Spaner, D; Yanke, J | 1 |
Boyce, TG; Yock, LC | 1 |
Al-Obaidi, MM; Khasawneh, FA | 1 |
Imöhl, M; van der Linden, M | 1 |
Arcinue, R; Elkhwad, M; Kantak, A | 1 |
Cole, NC; Greenwood-Quaintance, KE; Harper, LW; Ihde, SM; Kohner, PC; Mushtaq, A; Patel, R; Strand, GJ; Virk, A | 1 |
Aguirre Quiñonero, A; Angulo López, I; González Escartín, E; Ots Ruiz, E | 1 |
Badell, E; Benamrouche, N; Guettou, B; Guiso, N; Hasnaoui, S; Lazri, M; Rahal, K | 1 |
Almashanu, S; Bier Palmon, R; Eventov-Friedman, S; Flidel-Rimon, O; Golan, A; Kats, N; Keidar, R; Marom, R; Troitzky, M; Zung, A | 1 |
Dong, X; Feng, Y; Gao, L; Miao, J; Min, H; Wang, X; Xia, X; Zhang, C; Zhang, M; Zhao, J; Zhao, Y | 1 |
Devi Sekaran, S; Hossan, MS; Jindal, H; Kaharudin, F; Khoo, TJ; Maisha, S; Nissapatorn, V; Rahmatullah, M; Samudi Raju, C; Su Yi, L; Wiart, C | 1 |
Assefa, S; Desta, K; Lema, T | 1 |
Jayaraman, R; Kumar, JL; Neeravi, A; Ralph, R; Shanmugasundaram, D; Thomas, K; Varghese, R; Veeraraghavan, B | 1 |
Chen, PX; Fu, JL; Gu, XX; Jiang, HX; Yang, L; Zhang, LJ | 1 |
Ouyang, Y; Xu, YB; Zhao, D | 1 |
Chen, WQ; Gao, CY; Hu, DK; Jiang, XY; Li, XY; Luo, XH; Shen, WW; Yu, J; Zhang, J; Zhu, WS | 1 |
Booncharoen, S; Chaiyapoke, C; Chanawong, A; Lulitanond, A; Srisrattakarn, A; Tavichakorntrakool, R; Tippayawat, P; Wongthong, S | 1 |
Aouam, K; Ben Fadhel, N; Ben Fredj, N; Ben Romdhane, H; Chaabane, A; Chadli, Z; Mansour, K | 1 |
Amoureux, L; Casenaz, A; Guilloteau, A; Labattut, L; Magallon, A; Neuwirth, C; Piroth, L; Sixt, T | 1 |
Fan, X; Kang, X; Luo, S; Luo, X; Wang, G; Wei, Y; Zhao, S | 1 |
Liu, CL; Liu, XT; Qiu, J; Wen, ZQ; Zhang, ZH; Zhu, SY | 1 |
Husain, VI; Hussein, SA; Sulaiman, AM | 1 |
Fukushima, S; Gotoh, K; Hagiya, H; Otsuka, F; Uda, K | 1 |
7 review(s) available for vancomycin and cefotaxime
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Treatment failure with use of a third-generation cephalosporin for penicillin-resistant pneumococcal meningitis: case report and review.
Topics: Cefotaxime; Ceftriaxone; Drug Resistance, Microbial; Humans; Infant; Male; Meningitis, Pneumococcal; Microbial Sensitivity Tests; Penicillin Resistance; Rifampin; Streptococcus pneumoniae; Vancomycin | 1994 |
[Meningitis due to cefotaxime-resistant Streptococcus pneumoniae].
Topics: Anti-Bacterial Agents; Cefotaxime; Cephalosporins; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; Infant; Meningitis, Pneumococcal; Rifampin; Streptococcus pneumoniae; Vancomycin | 1996 |
Group C streptococcal meningitis: case report and review of the literature.
Topics: Adolescent; Anti-Bacterial Agents; Cefotaxime; Cephalosporins; Drug Therapy, Combination; Female; Humans; Meningitis, Bacterial; Streptococcal Infections; Streptococcus equi; Vancomycin | 2001 |
Management of pneumococcal meningitis.
Topics: Adult; Cefotaxime; Ceftriaxone; Dexamethasone; Drug Resistance; Drug Therapy, Combination; Humans; Infant; Meningitis, Pneumococcal; Streptococcus pneumoniae; Treatment Outcome; Vancomycin | 2002 |
[Cerebrospinal fluid rhinorrhea and Streptococcus equisimilis-related meningitis 16 years after a head injury].
Topics: Brain Injuries; Cefotaxime; Cerebrospinal Fluid Rhinorrhea; Drug Therapy, Combination; Frontal Lobe; Humans; Magnetic Resonance Imaging; Male; Meningitis, Bacterial; Middle Aged; Neurosurgical Procedures; Sphenoid Sinus; Streptococcal Infections; Streptococcus; Time Factors; Tomography, X-Ray Computed; Vancomycin | 2002 |
Fulminant Listeria monocytogenes meningitis complicated with acute hydrocephalus in healthy children beyond the newborn period.
Topics: Acute Disease; Amikacin; Cefotaxime; Child; Child, Preschool; Combined Modality Therapy; Costa Rica; Dexamethasone; Drug Resistance; Drug Therapy, Combination; Emergencies; Fatal Outcome; Female; Humans; Hydrocephalus; Male; Meningitis, Listeria; Meropenem; Rifampin; Thienamycins; Tomography, X-Ray Computed; Vancomycin; Ventriculostomy | 2004 |
3 trial(s) available for vancomycin and cefotaxime
Article | Year |
---|---|
[Cost savings by disinfection for prevention of surgical wound dehiscence after gastrectomy].
Topics: Aged; Amphotericin B; Antibiotic Prophylaxis; Cefotaxime; Cost Savings; Double-Blind Method; Drug Therapy, Combination; Female; Gastrectomy; Humans; Male; Middle Aged; Polymyxin B; Prospective Studies; Stomach Neoplasms; Surgical Wound Dehiscence; Surgical Wound Infection; Survival Rate; Tobramycin; Vancomycin | 1997 |
[Pneumococcal meningitis: a 2-year evaluation of the cefotaxime-vancomycin combination].
Topics: Adolescent; Anti-Bacterial Agents; Cefotaxime; Cephalosporins; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Male; Meningitis, Pneumococcal; Prospective Studies; Treatment Outcome; Vancomycin | 1999 |
Levels of vancomycin in cerebrospinal fluid of adult patients receiving adjunctive corticosteroids to treat pneumococcal meningitis: a prospective multicenter observational study.
Topics: Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Inflammatory Agents; Cefotaxime; Dexamethasone; Female; Humans; Male; Meningitis, Meningococcal; Meningitis, Pneumococcal; Middle Aged; Vancomycin | 2007 |
155 other study(ies) available for vancomycin and cefotaxime
Article | Year |
---|---|
The interaction and transport of beta-lactam antibiotics with the cloned rat renal organic anion transporter 1.
Topics: Animals; Anion Transport Proteins; Anti-Bacterial Agents; Biological Transport; Carrier Proteins; Cell Survival; Cephaloridine; Cephalosporins; In Vitro Techniques; Kidney; Kinetics; Oocytes; p-Aminohippuric Acid; Penicillin G; Rats; Recombinant Proteins; Xenopus laevis | 1999 |
Enols as potent antibacterial agents.
Topics: Acetamides; Anti-Bacterial Agents; Fluoroacetates; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Trifluoroacetic Acid | 2001 |
Synthesis, characterization and antimicrobial activity of Fe(II), Zn(II), Cd(II) and Hg(II) complexes with 2,6-bis(benzimidazol-2-yl) pyridine ligand.
Topics: Anti-Bacterial Agents; Antifungal Agents; Cadmium; Chelating Agents; Disk Diffusion Antimicrobial Tests; Ferrous Compounds; Ligands; Magnetic Resonance Spectroscopy; Metals, Heavy; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Organomercury Compounds; Organometallic Compounds; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis, Raman; Structure-Activity Relationship; Zinc | 2007 |
Clonal diversity and resistance mechanisms in tetracycline-nonsusceptible Streptococcus pneumoniae isolates in Poland.
Topics: Bacterial Proteins; Cell Lineage; DNA Transposable Elements; Genetic Variation; Poland; Streptococcus pneumoniae; Tetracycline; Tetracycline Resistance | 2007 |
Raman, FT-IR, NMR spectroscopic data and antimicrobial activity of bis[micro2-(benzimidazol-2-yl)-2-ethanethiolato-N,S,S-chloro-palladium(II)] dimer, [(micro2-CH2CH2NHNCC6H4)PdCl]2.C2H5OH complex.
Topics: Anti-Infective Agents; Bacteria; Disk Diffusion Antimicrobial Tests; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Molecular Structure; Organometallic Compounds; Palladium; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis; Spectrum Analysis, Raman; Yeasts | 2007 |
Daptomycin produces an enhanced bactericidal activity compared to ceftriaxone, measured by [3H]choline release in the cerebrospinal fluid, in experimental meningitis due to a penicillin-resistant pneumococcal strain without lysing its cell wall.
Topics: Animals; Anti-Bacterial Agents; Bacteriolysis; Ceftriaxone; Cell Wall; Cerebrospinal Fluid; Choline; Daptomycin; Disease Models, Animal; Humans; Meningitis, Pneumococcal; Microbial Sensitivity Tests; Penicillin Resistance; Rabbits; Streptococcus pneumoniae; Treatment Outcome; Tritium | 2007 |
Polyamine effects on antibiotic susceptibility in bacteria.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactams; Drug Resistance, Bacterial; Drug Synergism; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Polyamines; Spermine; Staphylococcus aureus | 2007 |
Prevalence, characteristics, and molecular epidemiology of macrolide and fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae at five tertiary-care hospitals in Korea.
Topics: Anti-Bacterial Agents; Community-Acquired Infections; DNA, Bacterial; Drug Resistance, Bacterial; Erythromycin; Fluoroquinolones; Genes, Bacterial; Hospitals; Humans; Korea; Levofloxacin; Macrolides; Microbial Sensitivity Tests; Molecular Epidemiology; Mutation; Ofloxacin; Pneumococcal Infections; Polymerase Chain Reaction; Prevalence; Reserpine; Respiratory Tract Infections; Retrospective Studies; Streptococcus pneumoniae | 2007 |
Serotypes, Clones, and Mechanisms of Resistance of Erythromycin-Resistant Streptococcus pneumoniae Isolates Collected in Spain.
Topics: Anti-Bacterial Agents; Clone Cells; Drug Resistance, Multiple, Bacterial; Electrophoresis, Polyacrylamide Gel; Erythromycin; Genes, Bacterial; Microbial Sensitivity Tests; Phenotype; Pneumococcal Infections; Serotyping; Spain; Streptococcus pneumoniae; Tetracycline Resistance | 2007 |
Synergy between polyethylenimine and different families of antibiotics against a resistant clinical isolate of Pseudomonas aeruginosa.
Topics: Aminoglycosides; Anti-Bacterial Agents; Carbenicillin; Ceftazidime; Ciprofloxacin; Drug Resistance, Bacterial; Drug Synergism; Humans; Microbial Sensitivity Tests; Novobiocin; Ofloxacin; Piperacillin; Polyethyleneimine; Pseudomonas aeruginosa; Pseudomonas Infections; Rifampin; Ticarcillin; Tobramycin | 2008 |
Clonal spread of highly beta-lactam-resistant Streptococcus pneumoniae isolates in Taiwan.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Genotype; Humans; Microbial Sensitivity Tests; Pneumococcal Infections; Serotyping; Streptococcus pneumoniae; Taiwan | 2008 |
Synthesis, Raman, FT-IR, NMR spectroscopic data and antimicrobial activity of mixed aza-oxo-thia macrocyclic compounds.
Topics: Anti-Infective Agents; Aza Compounds; Fungi; Gram-Negative Bacteria; Gram-Positive Bacteria; Ligands; Macrocyclic Compounds; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Molecular Structure; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis; Spectrum Analysis, Raman | 2009 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Microanalysis of beta-lactam antibiotics and vancomycin in plasma for pharmacokinetic studies in neonates.
Topics: Amoxicillin; Anti-Bacterial Agents; beta-Lactams; Cefazolin; Cefotaxime; Ceftriaxone; Chromatography, High Pressure Liquid; Humans; Infant, Newborn; Meropenem; Tandem Mass Spectrometry; Thienamycins; Vancomycin | 2009 |
Use of a surface plasmon resonance method to investigate antibiotic and plasma protein interactions.
Topics: Anti-Bacterial Agents; Blood Proteins; Protein Binding; Surface Plasmon Resonance | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Imcroporin, a new cationic antimicrobial peptide from the venom of the scorpion Isometrus maculates.
Topics: Amino Acid Sequence; Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Cefotaxime; Female; Hemolysis; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Molecular Sequence Data; Penicillins; Scorpion Venoms; Scorpions; Sequence Homology, Amino Acid; Staphylococcal Infections; Vancomycin | 2009 |
Synthesis, Raman, FT-IR, NMR spectroscopic characterization, antimicrobial activity, cytotoxicity and DNA binding of new mixed aza-oxo-thia macrocyclic compounds.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Apoptosis; Bacteria; Cattle; Cell Line, Tumor; DNA; Humans; Macrocyclic Compounds; Magnetic Resonance Spectroscopy; Models, Molecular; Molecular Structure; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis, Raman; Yeasts | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Distribution of serotypes, genotypes, and resistance determinants among macrolide-resistant Streptococcus pneumoniae isolates.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Child, Preschool; DNA Transposable Elements; Drug Resistance, Bacterial; Erythromycin; Genotype; Humans; Macrolides; Microbial Sensitivity Tests; New South Wales; Pneumococcal Infections; Serotyping; Streptococcus pneumoniae | 2010 |
Emergence of ciprofloxacin-nonsusceptible Streptococcus pyogenes isolates from healthy children and pediatric patients in Portugal.
Topics: Amino Acid Substitution; Anti-Bacterial Agents; Antigens, Bacterial; Bacterial Outer Membrane Proteins; Bacterial Typing Techniques; Carrier Proteins; Child; Ciprofloxacin; Drug Resistance, Bacterial; Humans; Molecular Epidemiology; Norfloxacin; Point Mutation; Portugal; Streptococcal Infections; Streptococcus pyogenes | 2010 |
Comparative in vitro activity profiles of novel bis-indole antibacterials against gram-positive and gram-negative clinical isolates.
Topics: Anti-Bacterial Agents; Gram-Negative Aerobic Bacteria; Gram-Positive Bacteria; Indoles; Microbial Sensitivity Tests | 2010 |
Tailoring cytotoxicity of antimicrobial peptidomimetics with high activity against multidrug-resistant Escherichia coli.
Topics: Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Antineoplastic Agents; Cell Proliferation; Circular Dichroism; Drug Resistance, Multiple; Gram-Negative Bacteria; Humans; Liposomes; Microbial Sensitivity Tests; Molecular Structure; Neoplasms; Peptidomimetics; Structure-Activity Relationship; Tumor Cells, Cultured | 2014 |
The Rational Design, Synthesis, and Antimicrobial Properties of Thiophene Derivatives That Inhibit Bacterial Histidine Kinases.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Drug Design; Enzyme Inhibitors; Histidine Kinase; Humans; Microbial Sensitivity Tests; Models, Molecular; Signal Transduction; Thiophenes | 2016 |
Bile Acid Oligomers and Their Combination with Antibiotics To Combat Bacterial Infections.
Topics: Anti-Bacterial Agents; Bile Acids and Salts; Drug Interactions; Drug Resistance, Bacterial; Escherichia coli; HEK293 Cells; Humans; Staphylococcus aureus | 2018 |
Anthraquinone-Based Specialized Metabolites from Rhizomes of
Topics: Anthraquinones; Anti-Bacterial Agents; Antifungal Agents; Asphodelaceae; Microbial Sensitivity Tests; Molecular Structure; Rhizome; Spectrum Analysis | 2019 |
Machine Learning in Mass Spectrometry: A MALDI-TOF MS Approach to Phenotypic Antibacterial Screening.
Topics: Anti-Bacterial Agents; Escherichia coli; Machine Learning; Microbial Sensitivity Tests; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Staphylococcus aureus | 2020 |
Novel Broad-Spectrum Antimicrobial Peptide Derived from Anoplin and Its Activity on Bacterial Pneumonia in Mice.
Topics: Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Antineoplastic Agents; Cell Line; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Molecular Structure; Pneumonia, Bacterial; Pore Forming Cytotoxic Proteins; Structure-Activity Relationship; Wasp Venoms | 2021 |
Metallo-β-lactamases inhibitor fisetin attenuates meropenem resistance in NDM-1-producing Escherichia coli.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Escherichia coli; Flavonols; Meropenem; Microbial Sensitivity Tests | 2022 |
Treatment of relapsing peritonitis in pediatric patients on peritoneal dialysis.
Topics: Adolescent; Cefotaxime; Child; Child, Preschool; Drug Therapy, Combination; Fosfomycin; Humans; Infant; Peritoneal Dialysis; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Prospective Studies; Recurrence; Thrombolytic Therapy; Urokinase-Type Plasminogen Activator; Vancomycin | 1992 |
[Bacteriostatic activity and killing curves of eight antibiotics against seven strains of penicillin G-resistant pneumococci].
Topics: Amoxicillin; Cefotaxime; Drug Synergism; Drug Therapy, Combination; Erythromycin; Fosfomycin; Humans; Imipenem; In Vitro Techniques; Penicillin G; Penicillin Resistance; Rifampin; Streptococcus pneumoniae; Vancomycin | 1992 |
Vancomycin resistance in Enterococcus gallinarum.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Carboxypeptidases; Carrier Proteins; Cefotaxime; Cefoxitin; Cell Membrane; Chromatography, High Pressure Liquid; Drug Resistance, Microbial; Enterococcus; Hexosyltransferases; Microbial Sensitivity Tests; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Peptidyl Transferases; Phenotype; Vancomycin | 1992 |
Effect of drug combinations on bilirubin-albumin binding.
Topics: Aminophylline; Bilirubin; Binding, Competitive; Cefotaxime; Drug Combinations; Drug Interactions; Humans; Infant, Newborn; Oxidation-Reduction; Phenobarbital; Serum Albumin; Vancomycin | 1991 |
Evaluation of intraosseous vs intravenous antibiotic levels in a porcine model.
Topics: Animals; Anti-Bacterial Agents; Bone Marrow; Cefotaxime; Chloramphenicol; Female; Infusions, Intravenous; Infusions, Parenteral; Male; Models, Biological; Prospective Studies; Swine; Tobramycin; Vancomycin | 1991 |
[Dosage adjustment of drugs during continuous hemofiltration. Results and practical consequences of a prospective clinical study].
Topics: Adult; Aged; Cefotaxime; Ceftazidime; Digitoxin; Digoxin; Hemofiltration; Humans; Imipenem; Kidney Failure, Chronic; Metronidazole; Middle Aged; Netilmicin; Pharmaceutical Preparations; Phenobarbital; Phenytoin; Theophylline; Tobramycin; Vancomycin | 1989 |
Activity of ciprofloxacin against multiply resistant strains of Pseudomonas aeruginosa, Staphylococcus epidermidis, and group JK corynebacteria.
Topics: Actinomycetales; Cefotaxime; Ciprofloxacin; Gentamicins; Humans; Methicillin; Mezlocillin; Microbial Sensitivity Tests; Norfloxacin; Penicillin Resistance; Pseudomonas aeruginosa; Staphylococcus epidermidis; Ticarcillin; Vancomycin | 1986 |
Determination of the effect of antimicrobics in combination against Listeria monocytogenes.
Topics: Anti-Bacterial Agents; Cefotaxime; Drug Combinations; Drug Synergism; Erythromycin; Gentamicins; Humans; Listeria monocytogenes; Microbial Sensitivity Tests; Moxalactam; Penicillin G; Rifampin; Sulfamethoxazole; Tetracycline; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 1987 |
[A case of pneumococcal meningitis resistant to beta-lactam antibiotic treatment].
Topics: Ampicillin; Ampicillin Resistance; Cefotaxime; Child, Preschool; Drug Resistance, Microbial; Humans; Male; Meningitis, Pneumococcal; Streptococcus pneumoniae; Vancomycin | 1988 |
Efficacy of a combination of cefotaxime, tobramycin and vancomycin as antibiotic therapy for neutropenia.
Topics: Agranulocytosis; Anti-Bacterial Agents; Bacterial Infections; Cefotaxime; Drug Therapy, Combination; Humans; Neutropenia; Tobramycin; Vancomycin | 1988 |
In vitro assessment of CI-934--a new quinolone derivative.
Topics: Anti-Bacterial Agents; Cefotaxime; Cefuroxime; Ciprofloxacin; Enoxacin; Erythromycin; Fluoroquinolones; Gentamicins; Kinetics; Naphthyridines; Quinolines; Streptococcus; Streptococcus pneumoniae; Vancomycin | 1986 |
Comparison of two antibiotic regimens for neonatal necrotizing enterocolitis.
Topics: Ampicillin; Anti-Bacterial Agents; Birth Weight; Cefotaxime; Clinical Protocols; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Feces; Gentamicins; Humans; Infant, Low Birth Weight; Infant, Newborn; Infant, Newborn, Diseases; Vancomycin | 1987 |
[Relapsing pseudomembranous colitis in uremia].
Topics: Cefotaxime; Cholestyramine Resin; Clindamycin; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Humans; Uremia; Vancomycin | 1986 |
Antimicrobial therapy of experimental meningitis caused by Streptococcus pneumoniae strains with different susceptibilities to penicillin.
Topics: Animals; Anti-Bacterial Agents; Cefotaxime; Ceftriaxone; Kinetics; Male; Meningitis, Pneumococcal; Microbial Sensitivity Tests; Penicillin G; Penicillin Resistance; Penicillins; Rabbits; Streptococcus pneumoniae; Vancomycin | 1985 |
Cefotaxime-associated diarrhea and Clostridium difficile.
Topics: Arthritis, Rheumatoid; Cefotaxime; Clostridium Infections; Colitis; Diarrhea; Female; Humans; Middle Aged; Prednisolone; Pulmonary Fibrosis; Vancomycin | 1984 |
In vitro bactericidal synergy of gentamicin combined with penicillin G, vancomycin, or cefotaxime against group G streptococci.
Topics: Cefotaxime; Drug Synergism; Gentamicins; Microbial Sensitivity Tests; Penicillin G; Streptococcus; Time Factors; Vancomycin | 1984 |
In vitro activity of cefmenoxime, cefotaxime, latamoxef, cefazolin, nafcillin and vancomycin against 53 endocarditis and bacteremic strains of Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Cefazolin; Cefmenoxime; Cefotaxime; Endocarditis, Bacterial; Humans; Microbial Sensitivity Tests; Moxalactam; Nafcillin; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1984 |
[Postpartum pseudomembranous colitis].
Topics: Adult; Cefotaxime; Colon; Colonoscopy; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Female; Gentamicins; Humans; Hysterectomy; Methylmethacrylates; Metronidazole; Obstetric Labor Complications; Pregnancy; Puerperal Disorders; Shock; Uterine Hemorrhage; Vancomycin | 1984 |
Effect of subinhibitory antibiotic concentrations on the phagocytosis of Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Blood Bactericidal Activity; Cefotaxime; Cefotiam; Clindamycin; Doxycycline; Humans; Neutrophils; Penicillin G; Penicillins; Phagocytosis; Piperacillin; Staphylococcus aureus; Vancomycin | 1982 |
Susceptibility of 50 isolates of Clostridium perfringens to cefotaxime, fosfomycin, penicillin G and vancomycin; variable tolerance for vancomycin.
Topics: Anti-Bacterial Agents; Cefotaxime; Clostridium perfringens; Fosfomycin; Microbial Sensitivity Tests; Penicillin G; Penicillin Resistance; Vancomycin | 1983 |
Measurement of levels of aminoglycosides and vancomycin in serum in the presence of new beta-lactam antibiotics.
Topics: Aminoglycosides; Anti-Bacterial Agents; Azlocillin; Cefoperazone; Cefotaxime; Humans; Immunoenzyme Techniques; Mezlocillin; Moxalactam; Penicillins; Piperacillin; Vancomycin | 1984 |
[Resistant pneumococcal meningitis revealing sickle cell anemia: efficacy of cefotaxime-vancomycin combination].
Topics: Anemia, Sickle Cell; Cefotaxime; Cephalosporins; Drug Therapy, Combination; Female; Humans; Infant; Meningitis, Pneumococcal; Penicillin Resistance; Vancomycin | 1995 |
Failure of cefotaxime treatment in a patient with penicillin-resistant pneumococcal meningitis and confirmation of nosocomial spread by random amplified polymorphic DNA analysis.
Topics: Base Sequence; Cefotaxime; Cephalosporins; Cross Infection; DNA Primers; DNA, Bacterial; Drug Therapy, Combination; Female; Gentamicins; Humans; Infant; Meningitis, Pneumococcal; Molecular Sequence Data; Penicillin Resistance; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Streptococcus pneumoniae; Treatment Failure; Vancomycin | 1995 |
[Treatment of Streptococcus pneumoiae meningitis in infants].
Topics: Cefotaxime; Ceftriaxone; Drug Therapy, Combination; Humans; Infant; Meningitis, Pneumococcal; Vancomycin | 1994 |
Meningitis due to ceftriaxone-resistant Streptococcus pneumoniae.
Topics: Adult; Cefotaxime; Humans; Male; Meningitis, Bacterial; Penicillin Resistance; Pneumococcal Infections; Streptococcus pneumoniae; Vancomycin | 1995 |
Combating drug-resistant pneumococcal infections.
Topics: Aged; Algorithms; Bacterial Vaccines; Cefotaxime; Cephalosporin Resistance; Chest Tubes; Combined Modality Therapy; Decision Trees; Diagnosis, Differential; Drug Resistance, Multiple; Drug Therapy, Combination; Humans; Male; Microbial Sensitivity Tests; Penicillin Resistance; Pleural Effusion; Pneumococcal Vaccines; Pneumonia, Pneumococcal; Rifampin; Streptococcus pneumoniae; Vancomycin | 1994 |
Cefixime and antibiotic-associated colitis.
Topics: Cefixime; Cefotaxime; Child; Child, Preschool; Enterocolitis, Pseudomembranous; Female; Humans; Male; Vancomycin | 1994 |
[Treatment of pneumococcal meningitis].
Topics: Cefotaxime; Humans; Male; Meningitis, Pneumococcal; Middle Aged; Penicillin Resistance; Vancomycin | 1994 |
Failure of cefotaxime in the treatment of meningitis due to relatively resistant Streptococcus pneumoniae.
Topics: Adult; Cefotaxime; Drug Resistance, Microbial; Humans; Injections, Intravenous; Injections, Spinal; Male; Meningitis, Bacterial; Penicillin Resistance; Streptococcal Infections; Streptococcus pneumoniae; Vancomycin | 1994 |
Incompatibility of cefotaxime sodium and vancomycin sulfate during Y-site administration.
Topics: Cefotaxime; Chemical Precipitation; Drug Incompatibility; Humans; Infant, Newborn; Infusions, Intravenous; Intensive Care Units, Neonatal; Vancomycin | 1993 |
Arterioportal fistula in infancy.
Topics: Angiography; Arteriovenous Fistula; Cefotaxime; Diagnosis, Differential; Female; Hepatic Artery; Humans; Infant, Newborn; Liver; Metronidazole; Portal Vein; Vancomycin | 1993 |
Occurrence of Streptococcus pneumoniae meningitis during vancomycin and cefotaxime therapy of septicemia in a patient with sickle cell disease.
Topics: Anemia, Sickle Cell; Bacteremia; Cefotaxime; Cephalosporins; Child; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Humans; Male; Meningitis, Pneumococcal; Microbial Sensitivity Tests; Pneumococcal Infections; Streptococcus pneumoniae; Vancomycin | 1995 |
Antibiotic-resistant pneumococci.
Topics: Anemia, Sickle Cell; Bacteremia; Cefotaxime; Cephalosporin Resistance; Child; Drug Therapy, Combination; Humans; Meningitis, Pneumococcal; Microbial Sensitivity Tests; Pneumococcal Infections; Streptococcus pneumoniae; Vancomycin | 1996 |
Prevalence of antibiotic resistance and serotypes in pneumococci in England and Wales: results of observational surveys in 1990 and 1995.
Topics: Anti-Bacterial Agents; Cefotaxime; Ceftriaxone; Drug Resistance, Microbial; England; Erythromycin; Humans; Penicillin Resistance; Pneumococcal Infections; Prevalence; Prospective Studies; Rifampin; Serotyping; Streptococcus pneumoniae; Vancomycin; Wales | 1996 |
Noncompromised penicillin-resistant pneumococcal pneumonia CBA/J mouse model and comparative efficacies of antibiotics in this model.
Topics: Animals; Anti-Bacterial Agents; Cefotaxime; Disease Models, Animal; Imipenem; Lung; Male; Mice; Mice, Inbred CBA; Mice, Inbred ICR; Microbial Sensitivity Tests; Penicillin G; Penicillin Resistance; Pneumonia, Pneumococcal; Species Specificity; Streptococcus pneumoniae; Vancomycin | 1996 |
In-vitro activity of psychiatric drugs against Corynebacterium urealyticum (Corynebacterium group D2).
Topics: 1-Naphthylamine; Amoxicillin; Anti-Bacterial Agents; Antidepressive Agents; Cefotaxime; Corynebacterium; Drug Therapy, Combination; Gentamicins; Microbial Sensitivity Tests; Paroxetine; Risperidone; Serotonin Antagonists; Sertraline; Teicoplanin; Vancomycin | 1996 |
Direct application of Etest to gram-positive cocci from blood cultures: quick and reliable minimum inhibitory concentration data.
Topics: Anti-Bacterial Agents; Blood; Cefotaxime; Cephalosporins; Culture Media; Erythromycin; Gentamicins; Gram-Positive Cocci; Imipenem; Microbial Sensitivity Tests; Penicillin G; Penicillins; Thienamycins; Vancomycin | 1996 |
MIC and time-kill study of activities of DU-6859a, ciprofloxacin, levofloxacin, sparfloxacin, cefotaxime, imipenem, and vancomycin against nine penicillin-susceptible and -resistant pneumococci.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Cefotaxime; Cell Division; Cephalosporins; Drug Resistance, Microbial; Fluoroquinolones; Imipenem; Microbial Sensitivity Tests; Quinolones; Streptococcus pneumoniae; Thienamycins; Time Factors; Vancomycin | 1996 |
Comparative investigation of drug delivery of collagen implants saturated in antibiotic solutions and a sponge containing gentamicin.
Topics: Anti-Bacterial Agents; Cefotaxime; Clindamycin; Collagen; Drug Delivery Systems; Fusidic Acid; Gentamicins; Microscopy, Electron, Scanning; Prostheses and Implants; Surgical Sponges; Vancomycin; Wound Infection | 1996 |
Antipneumococcal activities of cefpirome and cefotaxime, alone and in combination with vancomycin and teicoplanin, determined by checkerboard and time-kill methods.
Topics: Anti-Bacterial Agents; Cefotaxime; Cefpirome; Cephalosporins; Drug Synergism; Drug Therapy, Combination; Microbial Sensitivity Tests; Penicillin Resistance; Streptococcus pneumoniae; Teicoplanin; Time Factors; Vancomycin | 1996 |
Infections due to drug-resistant pneumococci, enterococci, and Mycobacterium tuberculosis.
Topics: Anti-Bacterial Agents; Cefotaxime; Cephalosporins; Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Mycobacterium tuberculosis; Pneumococcal Infections; Streptococcus pneumoniae; Tuberculosis, Multidrug-Resistant; Vancomycin | 1996 |
In-vivo activity and pharmacodynamics of cefotaxime in combination with vancomycin in fibrin clots infected with highly penicillin-resistant Streptococcus pneumoniae.
Topics: Analysis of Variance; Animals; Cefotaxime; Disease Models, Animal; Drug Therapy, Combination; Fibrin; Half-Life; Microbial Sensitivity Tests; Penicillin Resistance; Pneumococcal Infections; Rabbits; Thrombosis; Treatment Outcome; Vancomycin | 1996 |
Treatment of experimental pneumonia due to penicillin-resistant Streptococcus pneumoniae in immunocompetent rats.
Topics: Animals; Anti-Bacterial Agents; Cefotaxime; Cefpirome; Cephalosporins; Culture Media; Half-Life; Lung; Male; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Pneumonia, Pneumococcal; Rats; Rats, Wistar; Streptococcus pneumoniae; Vancomycin | 1997 |
[Studies on enrichment broth for verotoxin-producing Escherichia coli (VTEC) O157].
Topics: Aeromonas; Anti-Bacterial Agents; Bacterial Toxins; Bacteriological Techniques; Cefixime; Cefotaxime; Cephalosporins; Culture Media; Drug Resistance, Microbial; Escherichia coli O157; Novobiocin; Pseudomonas; Shiga Toxin 1; Tellurium; Temperature; Vancomycin | 1997 |
Decreased susceptibility to imipenem among penicillin-resistant Streptococcus pneumoniae.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Cefotaxime; Imipenem; Meropenem; Microbial Sensitivity Tests; Penicillin Resistance; Rifampin; Streptococcus pneumoniae; Thienamycins; Vancomycin | 1997 |
Bactericidal activity against intermediately cephalosporin-resistant Streptococcus pneumoniae in cerebrospinal fluid of children with bacterial meningitis treated with high doses of cefotaxime and vancomycin.
Topics: Adolescent; Anti-Bacterial Agents; Cefotaxime; Cephalosporin Resistance; Cephalosporins; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Infant; Meningitis, Bacterial; Microbial Sensitivity Tests; Pneumococcal Infections; Streptococcus pneumoniae; Vancomycin | 1997 |
[Therapeutic failure with high-dose cefotaxime in pneumococcal meningitis].
Topics: Anti-Bacterial Agents; Cefotaxime; Cephalosporin Resistance; Cephalosporins; Drug Therapy, Combination; Humans; Infant; Male; Meningitis, Pneumococcal; Streptococcus pneumoniae; Vancomycin | 1997 |
Penicillin-resistant pneumococcal meningitis in Israel.
Topics: Anti-Bacterial Agents; Cefotaxime; Cephalosporins; Humans; Infant; Israel; Male; Meningitis, Pneumococcal; Microbial Sensitivity Tests; Penicillin Resistance; Streptococcus pneumoniae; Vancomycin | 1997 |
[Resistance to antibiotics of Streptococcus pneumoniae strains].
Topics: Adult; Cefotaxime; Child; Clindamycin; Drug Resistance, Microbial; Erythromycin; Female; Humans; Male; Nose; Penicillin Resistance; Pharynx; Species Specificity; Sputum; Streptococcus pneumoniae; Tetracycline; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 1997 |
Clinical outcome of invasive infections by penicillin-resistant Streptococcus pneumoniae in Korean children.
Topics: Adolescent; Cefotaxime; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Female; Humans; Infant; Korea; Male; Microbial Sensitivity Tests; Penicillin G; Penicillin Resistance; Penicillins; Pneumococcal Infections; Retrospective Studies; Streptococcus pneumoniae; Vancomycin | 1998 |
Detection of hemolysin variants of Shiga toxin-producing Escherichia coli by PCR and culture on vancomycin-cefixime-cefsulodin blood agar.
Topics: Bacterial Toxins; Base Sequence; Blood; Cefixime; Cefotaxime; Cefsulodin; Culture Media; Escherichia coli; Feces; Food Microbiology; Hemolysin Proteins; Humans; Molecular Sequence Data; Sequence Alignment; Shiga Toxins; Vancomycin | 1998 |
Successful use of an intraosseous infusion in an 800 grams preterm infant.
Topics: Atropine; Bone Marrow; Cefotaxime; Dobutamine; Epinephrine; Fatal Outcome; Female; Fentanyl; Fluid Therapy; Humans; Infant, Newborn; Infant, Premature; Infant, Very Low Birth Weight; Infusions, Intraosseous; Respiratory Distress Syndrome, Newborn; Sodium Bicarbonate; Vancomycin | 1998 |
Anterior cervical spinal epidural abscess in an infant.
Topics: Abscess; Cefotaxime; Cervical Vertebrae; Drug Therapy, Combination; Epidural Space; Female; Hip Joint; Humans; Infant; Radiography; Spinal Diseases; Spinal Fusion; Staphylococcal Infections; Treatment Outcome; Vancomycin | 1999 |
Dissemination of a chloramphenicol- and tetracycline-resistant but penicillin-susceptible invasive clone of serotype 5 Streptococcus pneumoniae in Colombia.
Topics: Cefotaxime; Child, Preschool; Chloramphenicol; Chromosomes, Bacterial; Colombia; DNA, Bacterial; Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; Erythromycin; Geography; Humans; Infant; Microbial Sensitivity Tests; Penicillins; Pneumococcal Infections; Restriction Mapping; Serotyping; Streptococcus pneumoniae; Tetracycline Resistance; Vancomycin | 1999 |
Failure of treatment of pneumonia associated with highly resistant pneumococci in a child.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Cefotaxime; Cefuroxime; Cephalosporins; Drug Therapy, Combination; Humans; Infant; Lung; Male; Pneumonia, Pneumococcal; Radiography; Streptococcus pneumoniae; Treatment Failure; Vancomycin | 1999 |
Endocarditis due to Streptococcus mitis with high-level resistance to penicillin and cefotaxime.
Topics: Amoxicillin; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefotaxime; Cephalosporin Resistance; Endocarditis, Bacterial; Gentamicins; Humans; Male; Middle Aged; Penicillin Resistance; Streptococcal Infections; Vancomycin | 1999 |
Clinical outcomes of meningitis caused by Streptococcus pneumoniae in the era of antibiotic resistance.
Topics: Adolescent; Adult; Age Distribution; Aged; Anti-Bacterial Agents; Cefotaxime; Cephalosporin Resistance; Cephalosporins; Child; Child, Preschool; Female; Humans; Incidence; Infant; Infant, Newborn; Male; Meningitis, Pneumococcal; Middle Aged; Population Surveillance; Risk Factors; Streptococcus pneumoniae; Vancomycin | 2000 |
Antibiotic susceptibility profiles for group B streptococci isolated from neonates, 1995-1998.
Topics: Anti-Bacterial Agents; Bacterial Capsules; Cefotaxime; Chloramphenicol; Clindamycin; Drug Resistance, Microbial; Erythromycin; Female; Humans; Infant, Newborn; Microbial Sensitivity Tests; Ofloxacin; Penicillins; Sepsis; Serotyping; Streptococcal Infections; Streptococcus agalactiae; Tetracycline; Vancomycin | 2000 |
Solitary hepatic abscess with associated glomerulonephritis in a neonate.
Topics: Abscess; Anti-Bacterial Agents; Bacterial Infections; Cefotaxime; Cephalosporins; Drainage; Drug Therapy, Combination; Female; Glomerulonephritis; Humans; Infant, Newborn; Liver Diseases; Magnetic Resonance Imaging; Micrococcus; Staphylococcal Infections; Vancomycin | 2000 |
Invasive pneumococcal disease.
Topics: Anti-Bacterial Agents; Blood; Cefotaxime; Cephalosporins; Cerebrospinal Fluid; Diagnosis, Differential; Echocardiography, Transesophageal; Erythromycin; Female; Follow-Up Studies; Humans; Injections, Intravenous; Middle Aged; Penicillins; Pneumococcal Infections; Radiography, Thoracic; Streptococcus pneumoniae; Time Factors; Tomography, X-Ray Computed; Vancomycin | 2001 |
Bactericidal activity in cerebrospinal fluid by treating meningitis caused by Stomatococcus mucilaginosus with rifampicin, cefotaxime and vancomycin in a neutropenic child.
Topics: Anti-Bacterial Agents; Cefotaxime; Child, Preschool; Gram-Positive Bacterial Infections; Humans; Male; Meningitis, Bacterial; Micrococcaceae; Neutropenia; Rifampin; Vancomycin | 2001 |
Impregnation of vancomycin, gentamicin, and cefotaxime in a cement spacer for two-stage cementless reconstruction in infected total hip arthroplasty.
Topics: Adult; Aged; Anti-Bacterial Agents; Arthroplasty, Replacement, Hip; Bone Cements; Cefotaxime; Drug Therapy, Combination; Female; Gentamicins; Humans; Male; Middle Aged; Postoperative Complications; Prosthesis-Related Infections; Recurrence; Reoperation; Treatment Outcome; Vancomycin | 2001 |
Failure of cefotaxime and meropenem to eradicate meningitis caused by an intermediately susceptible Streptococcus pneumoniae strain.
Topics: Cefotaxime; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Infant; Meningitis, Pneumococcal; Meropenem; Microbial Sensitivity Tests; Severity of Illness Index; Spinal Puncture; Streptococcus pneumoniae; Thienamycins; Treatment Failure; Vancomycin | 2001 |
Outbreak of acute renal failure due to cefodizime-vancomycin association in a heart surgery unit.
Topics: Acute Kidney Injury; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cardiac Surgical Procedures; Cefotaxime; Cephalosporins; Disease Outbreaks; Female; Humans; Male; Middle Aged; Vancomycin | 2001 |
Staphylococcus warneri septicemia in preterm neonates - a reminder.
Topics: Cefotaxime; Cross Infection; Drug Therapy, Combination; Female; Humans; Infant, Newborn; Infant, Premature; Sepsis; Staphylococcal Infections; Vancomycin | 2002 |
Empirical treatment of adult postsurgical nosocomial meningitis.
Topics: Adult; Aged; Cefotaxime; Central Nervous System Diseases; Cerebrospinal Fluid Shunts; Craniotomy; Cross Infection; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fosfomycin; Humans; Male; Meningitis, Aseptic; Meningitis, Bacterial; Methicillin Resistance; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Staphylococcal Infections; Surgical Wound Infection; Treatment Outcome; Vancomycin | 2002 |
[Endophthalmitis following cataract surgery].
Topics: Amikacin; Cefotaxime; Ceftazidime; Combined Modality Therapy; Drug Therapy, Combination; Endophthalmitis; Follow-Up Studies; Humans; Infusions, Intravenous; Lenses, Intraocular; Postoperative Complications; Prosthesis-Related Infections; Recurrence; Reoperation; Retrospective Studies; Staphylococcal Infections; Vancomycin; Visual Acuity; Vitrectomy | 2002 |
[Rhône-Alpes observatory of Streptococcus pneumoniae in 1999: 35 cases of meningitis].
Topics: Adolescent; Adult; Aged; Amoxicillin; Cefotaxime; Child; Child, Preschool; Chloramphenicol; Drug Resistance, Microbial; Female; Fosfomycin; France; Humans; Infant; Male; Meningitis, Pneumococcal; Microbial Sensitivity Tests; Middle Aged; Penicillins; Retrospective Studies; Rifampin; Surveys and Questionnaires; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2002 |
[Highly-resistant Streptococcus pneumoniae meningitis in Central America].
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Cefotaxime; Central America; Humans; Infant; Male; Meningitis, Pneumococcal; Streptococcus pneumoniae; Vancomycin | 2003 |
Efficacy of vancomycin-beta-lactam combinations against heterogeneously vancomycin-resistant Staphylococcus aureus (hetero-VRSA).
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Cefotaxime; Drug Synergism; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Oxacillin; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2003 |
[Antimicrobial susceptibilities of Streptococcus pneumoniae and Haemophilus influenzae isolated from children with meningitis].
Topics: Ampicillin; Cefotaxime; Ceftriaxone; Child, Preschool; Drug Resistance, Bacterial; Haemophilus influenzae; Humans; Infant; Meningitis; Meropenem; Streptococcus pneumoniae; Thienamycins; Vancomycin | 2004 |
The glycopeptide vancomycin does not enhance toll-like receptor 2 (TLR2) activation by Streptococcus pneumoniae.
Topics: Anti-Bacterial Agents; beta-Lactams; Cefotaxime; Cell Wall; Cephalosporins; Genes, Reporter; HeLa Cells; Humans; Interleukin-8; Lactams; Lipopolysaccharide Receptors; Luciferases; Membrane Glycoproteins; Microbial Sensitivity Tests; Plasmids; Receptors, Cell Surface; Streptococcus pneumoniae; Toll-Like Receptor 2; Toll-Like Receptors; Transfection; Vancomycin | 2004 |
Pneumococcal-associated purpura fulminans in a healthy infant.
Topics: Cefotaxime; Combined Modality Therapy; Debridement; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Fever; Foot; Gangrene; Hand; Humans; IgA Vasculitis; Immunocompetence; Infant; Ischemia; Male; Physical Therapy Modalities; Plasma; Plastic Surgery Procedures; Pneumococcal Infections; Pneumonia, Pneumococcal; Sepsis; Skin Transplantation; Vancomycin | 2004 |
Use of simulated blood cultures for antibiotic effect on time to detection of the two blood culture systems BacT/ALERT and BACTEC 9240.
Topics: Ampicillin; Anti-Bacterial Agents; Bacteremia; Bacteria; Bacteriological Techniques; Blood; Cefotaxime; Ciprofloxacin; Culture Media; Enterococcus faecalis; Escherichia coli; Gentamicins; Staphylococcus aureus; Streptococcus pneumoniae; Time Factors; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2004 |
In vitro activities of cefotaxime, vancomycin, quinupristin/dalfopristin, linezolid and other antibiotics alone and in combination against Propionibacterium acnes isolates from central nervous system infections.
Topics: Acetamides; Cefotaxime; Central Nervous System Infections; Drug Therapy, Combination; Gram-Positive Bacterial Infections; Humans; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Propionibacterium acnes; Vancomycin; Virginiamycin | 2005 |
[Critical odontogenic infection involving the mediastinum. Case report].
Topics: Abscess; Ampicillin; Cefotaxime; Cellulitis; Combined Modality Therapy; Critical Care; Disease Progression; Empyema, Pleural; Follow-Up Studies; Humans; Male; Mediastinitis; Middle Aged; Neck; Reoperation; Shock, Septic; Staphylococcal Infections; Staphylococcus epidermidis; Streptococcal Infections; Sulbactam; Therapeutic Irrigation; Thoracotomy; Tomography, X-Ray Computed; Vancomycin | 2005 |
Early vancomycin therapy and adverse outcomes in children with pneumococcal meningitis.
Topics: Anti-Bacterial Agents; Cefotaxime; Ceftriaxone; Drug Therapy, Combination; Female; Hearing Loss, Sensorineural; Humans; Infant; Male; Meningitis, Pneumococcal; Survival Rate; Vancomycin | 2006 |
Antimicrobial susceptibility of invasive Streptococcus pneumoniae isolates in Portugal over an 11-year period.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Cefotaxime; Chloramphenicol; Ciprofloxacin; Clindamycin; Drug Resistance, Multiple; Erythromycin; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Ofloxacin; Penicillin Resistance; Penicillins; Population Surveillance; Portugal; Retrospective Studies; Serotyping; Streptococcus pneumoniae; Tetracycline; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2006 |
[Drug-resistance of staphylococcus aureus and detection of mecA gene in all strains isolated from children in Hangzhou].
Topics: Anti-Bacterial Agents; Bacterial Proteins; Cefotaxime; Ceftriaxone; Child; Child, Preschool; China; Drug Resistance, Bacterial; Erythromycin; Humans; Latex Fixation Tests; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxacillin; Penicillin-Binding Proteins; Penicillins; Polymerase Chain Reaction; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2006 |
Acquired hydrocephalus caused by a variant lymphocytic choriomeningitis virus.
Topics: Acyclovir; Anti-Bacterial Agents; Antiviral Agents; Brain; Cefotaxime; Child, Preschool; Humans; Hydrocephalus; Lymphocytic Choriomeningitis; Lymphocytic choriomeningitis virus; Magnetic Resonance Imaging; Male; RNA, Viral; Tomography, X-Ray Computed; Vancomycin; Ventriculoperitoneal Shunt; Ventriculostomy | 2006 |
[Implication of dexamethasone adjunctive therapy after the onset of cerebral vasculitis in Streptococcus pneumoniae meningitis].
Topics: Amoxicillin; Anti-Inflammatory Agents; Arthritis, Infectious; Brain Edema; Cefotaxime; Chemotherapy, Adjuvant; Coma; Dexamethasone; Drug Therapy, Combination; Emergencies; Encephalocele; Fatal Outcome; Fever; Humans; Knee Joint; Male; Meningitis, Pneumococcal; Middle Aged; Substance Withdrawal Syndrome; Vancomycin; Vasculitis, Central Nervous System | 2007 |
Bullous impetigo: a rare presentation in fulminant streptococcal toxic shock syndrome.
Topics: Anti-Bacterial Agents; Cardiotonic Agents; Cefotaxime; Clindamycin; Colloids; Combined Modality Therapy; Disseminated Intravascular Coagulation; Female; Humans; Impetigo; Infant; Plasma; Respiration, Artificial; Shock, Septic; Skin Diseases, Vesiculobullous; Streptococcal Infections; Streptococcus pyogenes; Vancomycin; Vitamin K | 2007 |
Ribosomal DNA assay of culture-negative Streptococcus pneumoniae meningitis.
Topics: Anti-Bacterial Agents; Brain; Cefotaxime; Child; DNA, Bacterial; DNA, Ribosomal; Drug Therapy, Combination; Epidural Abscess; False Negative Reactions; Female; Humans; Magnetic Resonance Imaging; Meningitis, Pneumococcal; Polymerase Chain Reaction; Spinal Cord; Streptococcus pneumoniae; Vancomycin | 2007 |
Spontaneous bacterial peritonitis in terminal renal failure.
Topics: Adult; Anti-Bacterial Agents; Ascites; Cefotaxime; Drug Therapy, Combination; Humans; Imipenem; Kidney Failure, Chronic; Male; Peritonitis; Renal Dialysis; Staphylococcal Infections; Staphylococcus epidermidis; Vancomycin | 2007 |
Meningitis in diabetic patients.
Topics: Anti-Bacterial Agents; Cefotaxime; Cohort Studies; Community-Acquired Infections; Diabetes Complications; Diabetes Mellitus; Humans; Meningitis, Bacterial; Outcome Assessment, Health Care; Risk Factors; Vancomycin | 2007 |
Outcome of renal transplantation in eight patients with Candida sp. contamination of preservation fluid.
Topics: Adult; Aged; Antifungal Agents; Cadaver; Candida; Candidiasis; Cefotaxime; Female; Humans; Kidney Transplantation; Male; Middle Aged; Organ Preservation Solutions; Postoperative Complications; Retrospective Studies; Tissue Donors; Transplants; Treatment Outcome; Vancomycin | 2008 |
Post operative penicillin-non-susceptible Streptococcus pneumoniae meningitis and septic shock in a child.
Topics: Anti-Bacterial Agents; Cefotaxime; Chloramphenicol; Drug Resistance, Bacterial; Female; Humans; Infant; Lincomycin; Meningoencephalitis; Pneumonia, Staphylococcal; Postoperative Complications; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2008 |
Infected lumbar dermoid cyst presenting with tetraparesis secondary to holocord central lesion.
Topics: Abscess; Cefotaxime; Child; Dermoid Cyst; Drug Therapy, Combination; Follow-Up Studies; Gram-Negative Bacterial Infections; Humans; Laminectomy; Lumbar Vertebrae; Magnetic Resonance Imaging; Male; Metronidazole; Neurologic Examination; Postoperative Care; Postoperative Complications; Quadriplegia; Sacrum; Spina Bifida Occulta; Spinal Cord; Spinal Cord Neoplasms; Vancomycin | 2008 |
Bilateral endophthalmitis in a patient with bacterial meningitis caused by Streptococcus pneumoniae.
Topics: Adult; Ampicillin; Anti-Bacterial Agents; Bacteremia; Cefotaxime; Ceftazidime; Cerebrospinal Fluid; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Functional Laterality; Humans; Male; Meningitis, Pneumococcal; Retinal Detachment; Scleral Buckling; Streptococcus pneumoniae; Vancomycin; Visual Acuity; Vitrectomy; Vitreoretinopathy, Proliferative | 2008 |
[Streptococcus pneumoniae 19A-induced hemolytic-uremic syndrome: a new pathology?].
Topics: Anti-Bacterial Agents; Blood Transfusion; Cefotaxime; Cerebrospinal Fluid; Drug Therapy, Combination; Hemolytic-Uremic Syndrome; Humans; Infant; Magnetic Resonance Imaging; Male; Pneumococcal Infections; Streptococcus pneumoniae; Treatment Outcome; Vancomycin | 2008 |
Meningitis.
Topics: Anti-Bacterial Agents; Cefotaxime; Ceftriaxone; Drug Therapy, Combination; Hearing Loss; Humans; Incidence; Infant; Intracranial Hypertension; Meningitis; Meningitis, Bacterial; Meningitis, Meningococcal; Vancomycin | 2008 |
A patient with penicillin-resistant viridans group streptococcal endocarditis and unusual reactions to vancomycin.
Topics: Adolescent; Anti-Bacterial Agents; Cefotaxime; Endocarditis, Bacterial; Female; Glucocorticoids; Humans; Penicillin Resistance; Prednisolone; Streptococcal Infections; Streptococcus mitis; Vancomycin | 2008 |
Varicella reactivation presenting as shingles and aseptic meningitis in an immunocompetent 11-year-old boy.
Topics: Acyclovir; Anti-Bacterial Agents; Antibodies, Viral; Antiviral Agents; Cefotaxime; Chickenpox; Child; Herpes Zoster; Herpesvirus 3, Human; Humans; Male; Meningitis, Aseptic; Polymerase Chain Reaction; Recurrence; Spinal Puncture; Vancomycin | 2009 |
Meningitis and epidural abscess related to pansinusitis.
Topics: Bacteroidaceae Infections; Cefotaxime; Ceftriaxone; Child; Combined Modality Therapy; Consciousness Disorders; Diagnostic Imaging; Drug Therapy, Combination; Eikenella; Emergencies; Endoscopy; Epidural Abscess; Female; Fusobacterium Infections; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Meningitis, Bacterial; Metronidazole; Otorhinolaryngologic Surgical Procedures; Peptostreptococcus; Prevotella intermedia; Sinusitis; Staphylococcal Infections; Vancomycin | 2009 |
An acute ischemic stroke secondary to sphenoid sinusitis.
Topics: Acute Disease; Acyclovir; Adult; Anti-Bacterial Agents; Anticoagulants; Antiviral Agents; Carotid Artery Diseases; Cefotaxime; Dalteparin; Dexamethasone; Female; Glucocorticoids; Humans; Magnetic Resonance Angiography; Sphenoid Sinusitis; Stroke; Tomography, X-Ray Computed; Vancomycin | 2009 |
Neck injury at a rural emergency department: perils, pitfalls and management considerations.
Topics: Adult; Anti-Bacterial Agents; Cefotaxime; Emergency Medical Services; Hospitals, Rural; Humans; Male; Meningitis; Neck Injuries; Pneumocephalus; Tomography, X-Ray Computed; Treatment Outcome; Vancomycin; Wounds, Stab | 2010 |
In vitro sensitivity and resistance of 46 Leptospira strains isolated from rats in the Philippines to 14 antimicrobial agents.
Topics: Amphotericin B; Ampicillin; Animals; Anti-Bacterial Agents; Cefotaxime; Ciprofloxacin; Doxycycline; Erythromycin; Fluorouracil; Fosfomycin; Leptospira; Microbial Sensitivity Tests; Neomycin; Philippines; Rats; Sulfamethoxazole; Trimethoprim; Vancomycin | 2010 |
Antibacterial action of a heat-stable form of L-amino acid oxidase isolated from king cobra (Ophiophagus hannah) venom.
Topics: Animals; Anti-Bacterial Agents; Cefotaxime; Dose-Response Relationship, Drug; Elapid Venoms; Escherichia coli; Gram-Negative Bacteria; Gram-Positive Bacteria; Hot Temperature; Humans; Kanamycin; Klebsiella pneumoniae; L-Amino Acid Oxidase; Microbial Sensitivity Tests; Penicillins; Pseudomonas aeruginosa; Staphylococcus aureus; Staphylococcus epidermidis; Tetracycline; Vancomycin | 2011 |
[Frontal sinusitis, mucocele and subperiosteal superolateral orbit abscess].
Topics: Abscess; Anti-Bacterial Agents; Cefotaxime; Child; Drainage; Drug Combinations; Exophthalmos; Frontal Sinusitis; Humans; Magnetic Resonance Imaging; Male; Metronidazole; Mucocele; Orbital Cellulitis; Radiography; Vancomycin | 2011 |
Identification of high-risk group and therapeutic options in children with liver abscess.
Topics: Adolescent; Anti-Infective Agents; Cefotaxime; Child; Child, Preschool; Cloxacillin; Drainage; Drug Therapy, Combination; Female; Humans; Leukocytosis; Liver Abscess; Male; Metronidazole; Neutrophils; Retrospective Studies; Risk Assessment; Treatment Outcome; Vancomycin | 2012 |
Changing trends in antimicrobial susceptibility of Streptococcus pneumoniae isolates in Taiwan, 2006-2007.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Cefotaxime; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Moxifloxacin; Penicillins; Quinolines; Streptococcus pneumoniae; Taiwan; Vancomycin | 2012 |
Thoracoscopic treatment of pediatric lung abscess.
Topics: Anti-Bacterial Agents; Bronchial Fistula; Cefotaxime; Chest Tubes; Combined Modality Therapy; Debridement; Drainage; Drug Therapy, Combination; Empyema, Pleural; Equipment Failure; Female; Humans; Infant; Lung Abscess; Male; Necrosis; Pleural Diseases; Pneumonia, Bacterial; Pneumothorax; Postoperative Complications; Radiography; Respiratory Tract Fistula; Therapeutic Irrigation; Thoracoscopy; Vancomycin | 2012 |
Neuroborreliosis presenting as acute disseminated encephalomyelitis.
Topics: Brain Damage, Chronic; Cefotaxime; Ceftriaxone; Child, Preschool; Coma; Diazepam; Encephalomyelitis, Acute Disseminated; Facial Paralysis; Humans; Immunoglobulins, Intravenous; Lyme Neuroborreliosis; Magnetic Resonance Imaging; Male; Mastoiditis; Methylprednisolone; Portugal; Respiration, Artificial; Respiratory Insufficiency; Respiratory Tract Infections; Seizures; Sinusitis; Vancomycin | 2012 |
Cefotaxime prevents microbial contamination and improves microspore embryogenesis in wheat and triticale.
Topics: Anti-Bacterial Agents; Cefotaxime; Culture Media; Edible Grain; Gram-Negative Bacteria; Microbial Sensitivity Tests; Pollen; Triticum; Vancomycin | 2013 |
Fever and abdominal pain following incision and drainage of a cutaneous abscess.
Topics: Abdominal Pain; Abscess; Anti-Bacterial Agents; Cefazolin; Cefotaxime; Child, Preschool; Drainage; Fever; Humans; Kidney; Kidney Diseases; Male; Pyelonephritis; Staphylococcus aureus; Tomography, X-Ray Computed; Vancomycin | 2015 |
Progressive headache in a 48-year-old man.
Topics: Anti-Bacterial Agents; Brain; Brain Abscess; Cefotaxime; Drug Therapy, Combination; Headache; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Tomography, X-Ray Computed; Vancomycin | 2015 |
Antimicrobial Susceptibility of Invasive Streptococcus pyogenes Isolates in Germany during 2003-2013.
Topics: Anti-Bacterial Agents; Cefotaxime; Chloramphenicol; Clindamycin; Epidemiological Monitoring; Germany; Humans; Levofloxacin; Macrolides; Microbial Sensitivity Tests; Penicillins; Streptococcal Infections; Streptococcus pyogenes; Tetracycline; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2015 |
Acute kidney injury in ELBW infants (< 750 grams) and its associated risk factors.
Topics: Abruptio Placentae; Acute Kidney Injury; Adult; Amphotericin B; Anti-Bacterial Agents; Case-Control Studies; Cefotaxime; Clindamycin; Creatinine; Diuretics; Ductus Arteriosus, Patent; Enterocolitis, Necrotizing; Female; Furosemide; Humans; Hydrochlorothiazide; Infant, Extremely Low Birth Weight; Infant, Newborn; Infections; Intracranial Hemorrhages; Ohio; Parenteral Nutrition, Total; Pregnancy; Prevalence; Respiration, Artificial; Retrospective Studies; Risk Factors; Steroids; Survival Rate; Time Factors; Uterine Hemorrhage; Vancomycin; Young Adult | 2015 |
Differential Antimicrobial Susceptibilities of Granulicatella adiacens and Abiotrophia defectiva.
Topics: Abiotrophia; Anti-Infective Agents; Carnobacteriaceae; Cefepime; Cefotaxime; Cephalosporins; Clindamycin; Erythromycin; Levofloxacin; Microbial Sensitivity Tests; Penicillins; Vancomycin | 2016 |
[Simultaneous pneumococcal and enterovirus meningitis in an infant].
Topics: Anti-Bacterial Agents; Cefotaxime; Coinfection; Disease Outbreaks; Disease Susceptibility; Drug Therapy, Combination; Enterovirus Infections; Female; Humans; Infant; Magnetic Resonance Imaging; Meningitis, Pneumococcal; Meningitis, Viral; Seasons; Vancomycin | 2017 |
Microbiological and molecular characterization of Corynebacterium diphtheriae isolated in Algeria between 1992 and 2015.
Topics: Adult; Algeria; Anti-Bacterial Agents; Cefotaxime; Chloramphenicol; Corynebacterium diphtheriae; Diphtheria; Drug Resistance, Multiple, Bacterial; Erythromycin; Female; Genotyping Techniques; Gentamicins; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Epidemiology; Multilocus Sequence Typing; Penicillin G; Phylogeny; Rhinitis, Atrophic; Tetracycline; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin; Young Adult | 2016 |
Risk Factors for the Development of Delayed TSH Elevation in Neonatal Intensive Care Unit Newborns.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antifungal Agents; Cefotaxime; Cesarean Section; Diuretics; Dopamine; Ductus Arteriosus, Patent; Erythrocyte Transfusion; Female; Fluconazole; Furosemide; Humans; Hypoglycemic Agents; Hypothyroidism; Ibuprofen; Infant, Low Birth Weight; Infant, Newborn; Infant, Premature; Insulin; Intensive Care Units, Neonatal; Male; Multivariate Analysis; Neonatal Screening; Pneumothorax; Respiration, Artificial; Retrospective Studies; Risk Factors; Sympathomimetics; Thyrotropin; Time Factors; Vancomycin | 2017 |
Human infection with a novel H7N9 avian influenza virus in Yunnan, China.
Topics: Anti-Bacterial Agents; Antiviral Agents; Cefotaxime; China; Drug Therapy, Combination; Female; Humans; Influenza A Virus, H7N9 Subtype; Influenza, Human; Oseltamivir; Tomography, X-Ray Computed; Vancomycin; Young Adult | 2018 |
Antibacterial effects of 18 medicinal plants used by the Khyang tribe in Bangladesh.
Topics: Anti-Bacterial Agents; Bacteria; Bangladesh; Cefotaxime; Drug Resistance, Bacterial; Drug Synergism; Humans; Medicine, Traditional; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Phytotherapy; Plant Extracts; Plants, Medicinal; Time Factors; Vancomycin | 2018 |
Group B streptococci vaginal colonization and drug susceptibility pattern among pregnant women attending in selected public antenatal care centers in Addis Ababa, Ethiopia.
Topics: Adolescent; Adult; Ampicillin; Anti-Bacterial Agents; Carrier State; Cefotaxime; Chloramphenicol; Clindamycin; Cross-Sectional Studies; Disk Diffusion Antimicrobial Tests; Drug Resistance, Multiple, Bacterial; Erythromycin; Ethiopia; Female; Humans; Prevalence; Prospective Studies; Risk Factors; Streptococcus agalactiae; Tetracycline; Vagina; Vancomycin; Young Adult | 2018 |
Invasive pneumococcal disease in Indian adults: 11 years' experience.
Topics: Adult; Aged; Anti-Bacterial Agents; Cefotaxime; Cephalosporins; Comorbidity; Drug Resistance, Bacterial; Epidemiological Monitoring; Female; Humans; India; Male; Meningitis; Microbial Sensitivity Tests; Middle Aged; Mortality; Penicillin Resistance; Penicillins; Pneumococcal Infections; Pneumococcal Vaccines; Pneumonia; Prevalence; Prospective Studies; Serogroup; Streptococcus pneumoniae; Vaccines, Conjugate; Vancomycin; Young Adult | 2019 |
The first isolation of Clostridium difficile RT078/ST11 from pigs in China.
Topics: Animals; Anti-Bacterial Agents; Cefotaxime; Cefoxitin; Chickens; China; Ciprofloxacin; Clostridioides difficile; Ducks; Imipenem; Metronidazole; Molecular Epidemiology; Multilocus Sequence Typing; Polymerase Chain Reaction; Ribotyping; Swine; Tetracycline; Vancomycin | 2019 |
Curative effects of vancomycin and cefotaxime combined with gamma globulin respectively in neonatal septicemia and their influences on PCT, CRP and hs-CRP.
Topics: C-Reactive Protein; Cefotaxime; Drug Therapy, Combination; Female; gamma-Globulins; Humans; Infant, Newborn; Injections, Intravenous; Male; Procalcitonin; Sepsis; Vancomycin | 2020 |
Homology analysis of 51 penicillin-intermediate
Topics: Anti-Bacterial Agents; Cefotaxime; Ceftriaxone; Child, Preschool; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Humans; Infant; Male; Microbial Sensitivity Tests; Molecular Typing; Penicillin Resistance; Penicillins; Pneumonia, Pneumococcal; Polymerase Chain Reaction; Retrospective Studies; Sequence Homology, Nucleic Acid; Streptococcus pneumoniae; Vancomycin | 2020 |
Synergistic effect of vancomycin combined with cefotaxime, imipenem, or meropenem against Staphylococcus aureus with reduced susceptibility to vancomycin
Topics: Anti-Bacterial Agents; beta-Lactams; Cefotaxime; Drug Synergism; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2021 |
Cefotaxime-induced drug reaction with eosinophilia and systemic symptom in a child with cross-reactivity to other cephalosporins and cosensitization to teicoplanin.
Topics: Adult; Cefotaxime; Cephalosporins; Child; Child, Preschool; Drug Hypersensitivity Syndrome; Eosinophilia; Humans; Male; Metronidazole; Teicoplanin; Vancomycin | 2023 |
Epidemiology and antibiotic resistance of prosthetic joint infections according to time of occurrence, a 10-year study.
Topics: Anti-Bacterial Agents; Arthritis, Infectious; Cefotaxime; Coagulase; Drug Resistance, Microbial; Gram-Negative Bacteria; Humans; Imipenem; Microbial Sensitivity Tests; Piperacillin; Prosthesis-Related Infections; Retrospective Studies; Staphylococcus aureus; Tazobactam; Vancomycin | 2022 |
Analysis of virulence genes, drug resistance detection, and pathogenicity in Enterococcus from farm animals.
Topics: Animals; Animals, Domestic; Anti-Bacterial Agents; Cattle; Cefotaxime; Chickens; Ciprofloxacin; Dogs; Drug Resistance; Drug Resistance, Bacterial; Enterococcus; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Levofloxacin; Mice; Microbial Sensitivity Tests; Sulfamethoxazole; Swine; Vancomycin; Virulence; Virulence Factors | 2022 |
[Distribution and Drug Resistance of Pathogens in Oral Mucositis Associated with Chemotherapy in Patients with Malignant Hematopathy].
Topics: Ampicillin; Anti-Bacterial Agents; Cefotaxime; Cefuroxime; Drug Resistance, Bacterial; Gentamicins; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Levofloxacin; Oral Ulcer; Penicillins; Stomatitis; Vancomycin | 2023 |
Detection of Antibiotic Resistance Genes (
Topics: Anti-Bacterial Agents; Bacteremia; Cefotaxime; Ceftriaxone; Child; Child, Preschool; Drug Resistance, Microbial; Enterococcus faecalis; Escherichia coli; Humans; Infant; Reverse Transcriptase Polymerase Chain Reaction; Staphylococcus aureus; Vancomycin | 2023 |
Current Prevalence of Antimicrobial Resistance in Okayama from a National Database between 2018 and 2021.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Cefotaxime; Drug Resistance, Bacterial; Escherichia coli; Humans; Klebsiella pneumoniae; Levofloxacin; Meropenem; Methicillin-Resistant Staphylococcus aureus; Prevalence; Vancomycin | 2023 |